𝔖 Bobbio Scriptorium
✦   LIBER   ✦

TRANSFORMING GROWTH FACTOR β1 AND SOLUBLE FAS SERUM LEVELS IN HEPATOCELLULAR CARCINOMA

✍ Scribed by Rodolfo Sacco; Domenico Leuci; Cosimo Tortorella; Giorgio Fiore; Felice Marinosci; Salvatore Antonaci

Book ID
115596477
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
89 KB
Volume
12
Category
Article
ISSN
1043-4666

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene mutation of transforming growth fac
Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma
✍ Keiko Furuta; Sachiko Misao; Kiyoshi Takahashi; Tsuneaki Tagaya; Yoshitaka Fukuz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB 👁 1 views

Alteration of transforming growth factor beta1 (TGF-beta1) type II receptor (RII) appears to cause unresponsiveness to TGF-beta1 in tumorigenic cells. Defect in the mononucleotide repeat sequence, i.e., poly A region of TGF-beta1RII gene has been reported to be related to replication error-positive

Elevated serum levels of transforming gr
Elevated serum levels of transforming growth factor β1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients
✍ Jingwu Xu; José Menezes; U. Prasad; Ali Ahmad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB 👁 1 views

Nasopharyngeal carcinomas (NPCs) of non-keratinizing type are strongly associated with Epstein-Barr virus (EBV). EBV and its gene products induce the synthesis and/or release of transforming growth factor ␤1 (TGF-␤1) from human cells and platelets. TGF-␤1 is an immunosuppressive cytokine, and many t